Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Gross-Profit" stands at 50.31 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Merck & Company Inc's third quarter result of 14.15 Billion USD for the item "Gross Profit" represents an increase of 15.54 percent compared to it's second quarter result.
Also, Merck & Company Inc's third quarter result of 14.15 Billion USD for the item "Gross Profit" represents an increase of 12.52 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 50.31 Billion USD for the item "Gross Profit" represents an increase of 3.23 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 5.03 percent compared to the value the year prior.
The 1 year change in percent is 5.03.
The 3 year change in percent is 21.02.
The 5 year change in percent is 59.88.
The 10 year change in percent is 101.78.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit | 905,699,262,464.00 |
![]() | Johnson & Johnson - Gross Profit | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit | 280,205,508,085.11 |